Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

September 10, 2013 09:05 ET | Source: Melinta Therapeutics, Inc.

Cempra to Present Data at ICAAC on Solithromycin's (CEM-101) Activity Against a Broad Range of Pathogens Including Four Proposed or Designated by the Food and Drug Administration as Qualified Infectious Disease Pathogens (QIDP) Under the Generating Antibiotic Incentives Now (GAIN) Act

CHAPEL HILL, N.C., Sept. 10, 2013 (GLOBE NEWSWIRE) -- Cempra, Inc. (Nasdaq:CEMP), a clinical-stage pharmaceutical company focused on developing differentiated antibiotics to meet critical medical...
September 06, 2013 08:00 ET | Source: Melinta Therapeutics, Inc.

Cempra's Solithromycin (CEM-101) Receives Qualified Infectious Disease Product Designation From the U.S. Food and Drug Administration

CHAPEL HILL, N.C., Sept. 6, 2013 (GLOBE NEWSWIRE) -- Cempra, Inc. (Nasdaq:CEMP), a clinical-stage pharmaceutical company focused on developing differentiated antibiotics to meet critical medical needs...
September 05, 2013 08:00 ET | Source: Melinta Therapeutics, Inc.

Cempra's Solithromycin Demonstrates Safety and Tolerability in Patients With Chronic Liver Disease

CHAPEL HILL, N.C., Sept. 5, 2013 (GLOBE NEWSWIRE) -- Cempra, Inc. (Nasdaq:CEMP), a clinical-stage pharmaceutical company focused on developing differentiated antibiotics to meet critical medical needs...
September 03, 2013 16:48 ET | Source: Melinta Therapeutics, Inc.

Cempra, Inc. to Present at Baird's 2013 Health Care Conference and Stifel Healthcare Conference 2013

CHAPEL HILL, N.C., Sept. 3, 2013 (GLOBE NEWSWIRE) -- Cempra, Inc. (Nasdaq:CEMP), a clinical-stage pharmaceutical company focused on developing antibiotics to meet critical medical needs in the...
July 30, 2013 16:00 ET | Source: Melinta Therapeutics, Inc.

Cempra, Inc. Reports Second Quarter 2013 Financial and Operating Results

CHAPEL HILL, N.C., July 30, 2013 (GLOBE NEWSWIRE) -- Cempra, Inc. (Nasdaq:CEMP), a clinical-stage pharmaceutical company focused on developing antibiotics to meet critical medical needs in the...
July 23, 2013 16:05 ET | Source: Melinta Therapeutics, Inc.

Cempra, Inc. to Report Second Quarter 2013 Financial and Operating Results, and Host Conference Call and Webcast on July 30, 2013

CHAPEL HILL, N.C., July 23, 2013 (GLOBE NEWSWIRE) -- Cempra, Inc. (Nasdaq:CEMP) today announced that it will report second quarter 2013 financial results and provide a business update after the close...
June 19, 2013 16:01 ET | Source: Melinta Therapeutics, Inc.

Cempra Announces Partial Exercise of Over-Allotment Option and Completion of the Public Offering of Common Stock

CHAPEL HILL, N.C., June 19, 2013 (GLOBE NEWSWIRE) -- Cempra, Inc. (Nasdaq:CEMP), a clinical-stage pharmaceutical company focused on developing differentiated antibiotics to meet critical medical needs...